BI1744-HCl
Pwodwi detay
Tags pwodwi
Gwosè pake | Disponibilite | Pri (USD) |
25 mg | Nan stock | 210 |
100 mg | Nan stock | 530 |
250 mg | Nan stock | 900 |
1000mg | Nan stock | 1650 |
Non Chimik:
(R)-6-hydroxy-8-(1-hydroxy-2-((1-(4-methoxyphenyl)-2-methylpropan-2-yl)amino)ethyl)-2H-benzo[b][1,4 ]oxazin-3(4H)-yon idroklorid
Kòd SMILES:
O=C1NC2=CC(O)=CC([C@@H](O)CNC(C)(C)CC3=CC=C(OC)C=C3)=C2OC1.[H]Cl
Kòd InChi:
InChI=1S/C21H26N2O5.ClH/c1-21(2,10-13-4-6-15(27-3)7-5-13)22-11-18(25)16-8-14(24) 9-1 7-20(16)28-12-19(26)23-17;/h4-9,18,22,24-25H,10-12H2,1-3H3,(H,23,26);1H/t18 -;/m0./s1
InChi kle:
KCEHVJZZIGJAAW-FERBBOLQSA-N
Mot:
BI-1744, Striverdi, 868049-49-4
Solibilite:Soluble nan H2O
Depo:0 - 4 ° C pou kout tèm (jou a semèn), oswa -20 ° C pou tèm long (mwa).
Deskripsyon:
BI 1744, se yon agonist beta-adrenoceptor ki itilize kòm yon rale pou trete pasyan ki gen maladi poumon kwonik obstriktif (COPD), ki fabrike pa Boehringer-Ingelheim.
Sib: LABA